Expected a Drastic Growth in Famciclovir API Industry

Expected a Drastic Growth in Famciclovir API Industry

Famciclovir is an antiviral guanosine analog used to treat various herpesvirus infections, most common in herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is sold under the trade name Famvir (Novartis).

Get Sample PDF

Leading players of Famciclovir API Industry:

Chongqing Shenghuaxi Pharma, Aurobindo Pharma Limited, Apotex Pharmachem, Changzhou Kony Pharma Co, Teva Pharmaceutical Industries, Olon, Fuan Pharmaceutical, Zhejiang Charioteer Pharmaceutical, Jialin Pharmaceutical, Zhejiang Hisun, Hetero

Famciclovir was patented in 1983 and approved for medical use in 1994. In 2007, the US Food and Drug Administration approved the first generic version of famciclovir. Generic tablets are made by TEVA Pharmaceuticals and Mylan Pharmaceuticals.

Famciclovir is indicated for the treatment of herpes zoster (shingles), for the treatment of herpes simplex virus 2 (genital herpes), herpes labialis (cold sores) in immunocompetent patients and for the suppression of recurrent episodes of herpes simplex virus 2, for the treatment of recurrent episodes of herpes simplex in HIV patients.

Comments

Popular posts from this blog

Latest Innovation Knocking-in Luxuries Industry

Urgent Care Centers Market

Future Scope for Deep Sea Exploration Robot Industry